SCHEMBL344922

SCHEMBL344922

CCOC(=O)c1cc(COC(=O)NCC2(F)CCN(c3nccc(C(F)(F)F)n3)CC2)on1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 3/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2331284 0.90 ADRB1 (0.40) ADRB1HDAC6ALDH1A1KDM4ECHRM4
SCHEMBL346214 0.85 SLC6A2 (0.37) ADRB1MEN1KMT2AMAPTHSD17B10
SCHEMBL345783 0.79 RAB9A (0.39) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL16161721 0.77 ADRB1 (0.50) ADRB1KMT2AHDAC6ALDH1A1KDM4E
SCHEMBL346185 0.77 PKM (0.42) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL345077 0.76 HTR3A (0.39) MEN1KMT2ARAB9AMAPTKCNH2
Trifluoroacetic Acid SCHEMBL345531 0.75 KMT2A (0.34) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL345643 0.72 HDAC6 (0.38) ADRB1HDAC6ALDH1A1KDM4ECHRM4
SCHEMBL344924 0.71 SYK (0.35) HSD17B10ALDH1A1HPGDKDM4ETP53
SCHEMBL8512521 0.71 MAPT (0.36) MEN1KMT2ARAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716289-B2 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-05-06 US disclosed
US-20120015950-A1 CARBAMATE DERIVATIVES OF ALKYL-HETEROCYCLES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015950-A1 CARBAMATE DERIVATIVES OF ALKYL-HETEROCYCLES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF INTS9, CDK8, SCN8A ADRB1 1968/4885MEN1 812/4885KMT2A 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.